Skip to main navigation Skip to search Skip to main content

FROzEN - AF: Safety and Effectiveness IDE trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Project: Research

Project Details

StatusFinished
Effective start/end date02/28/2112/31/22

Funding

  • Boston Scientific Corporation: $15,794.00